View in EDS

MK-2206 and Standard Neoadjuvant Chemotherapy Improves Response in Patients With Human Epidermal Growth Factor Receptor 2-Positive and/or Hormone Receptor-Negative Breast Cancers in the I-SPY 2 Trial.

Saved in:
Bibliographic Details
Title: MK-2206 and Standard Neoadjuvant Chemotherapy Improves Response in Patients With Human Epidermal Growth Factor Receptor 2-Positive and/or Hormone Receptor-Negative Breast Cancers in the I-SPY 2 Trial.
Authors: Chien AJ; University of California, San Francisco, San Francisco, CA., Tripathy D; The University of Texas, MD Anderson Cancer Center, Houston, TX., Albain KS; Loyola University, Chicago, IL., Symmans WF; The University of Texas, MD Anderson Cancer Center, Houston, TX., Rugo HS; University of California, San Francisco, San Francisco, CA., Melisko ME; University of California, San Francisco, San Francisco, CA., Wallace AM; University of California, San Diego, La Jolla, CA., Schwab R; University of California, San Diego, La Jolla, CA., Helsten T; University of California, San Diego, La Jolla, CA., Forero-Torres A; University of Alabama at Birmingham, Birmingham, AL., Stringer-Reasor E; University of Alabama at Birmingham, Birmingham, AL., Ellis ED; Swedish Cancer Institute, Seattle, WA., Kaplan HG; Swedish Cancer Institute, Seattle, WA., Nanda R; The University of Chicago Medical Center, Chicago, IL., Jaskowiak N; The University of Chicago Medical Center, Chicago, IL., Murthy R; The University of Texas, MD Anderson Cancer Center, Houston, TX., Godellas C; Loyola University, Chicago, IL., Boughey JC; Mayo Clinic, Rochester, MN., Elias AD; University of Colorado Denver, Denver, CO., Haley BB; University of Texas Southwestern, Dallas, TX., Kemmer K; Oregon Health & Science University, Portland, OR., Isaacs C; Georgetown University, Washington, DC., Clark AS; University of Pennsylvania, Philadelphia, PA., Lang JE; University of Southern California, Los Angeles, CA., Lu J; University of Southern California, Los Angeles, CA., Korde L; Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD., Edmiston KK; Inova Health System, Falls Church, VA., Northfelt DW; Mayo Clinic, Scottsdale, AZ., Viscusi RK; University of Arizona, Tucson, AZ., Yee D; Masonic Cancer Center, University of Minnesota, Minneapolis, MN., Perlmutter J; Gemini Group, Bad Axe, MI., Hylton NM; University of California, San Francisco, San Francisco, CA., Van't Veer LJ; University of California, San Francisco, San Francisco, CA., DeMichele A; University of Pennsylvania, Philadelphia, PA., Wilson A; Quantum Leap Healthcare Collaborative, San Francisco, CA., Peterson G; University of California, San Francisco, San Francisco, CA., Buxton MB; Berry Consultants, Austin, TX., Paoloni M; Berry Consultants, Austin, TX., Clennell J; Berry Consultants, Austin, TX., Berry S; Berry Consultants, Austin, TX., Matthews JB; University of California, San Francisco, San Francisco, CA., Steeg K; University of California, San Francisco, San Francisco, CA., Singhrao R; University of California, San Francisco, San Francisco, CA., Hirst GL; University of California, San Francisco, San Francisco, CA., Sanil A; Berry Consultants, Austin, TX., Yau C; University of California, San Francisco, San Francisco, CA., Asare SM; Quantum Leap Healthcare Collaborative, San Francisco, CA., Berry DA; Berry Consultants, Austin, TX., Esserman LJ; University of California, San Francisco, San Francisco, CA.
Corporate Authors: I-SPY 2 Consortium
Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2020 Apr 01; Vol. 38 (10), pp. 1059-1069. Date of Electronic Publication: 2019 Feb 07.
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Adaptive Clinical Trial
Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32031889
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: MK-2206 and Standard Neoadjuvant Chemotherapy Improves Response in Patients With Human Epidermal Growth Factor Receptor 2-Positive and/or Hormone Receptor-Negative Breast Cancers in the I-SPY 2 Trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Chien+AJ%22">Chien AJ</searchLink>; University of California, San Francisco, San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Tripathy+D%22">Tripathy D</searchLink>; The University of Texas, MD Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Albain+KS%22">Albain KS</searchLink>; Loyola University, Chicago, IL.<br /><searchLink fieldCode="AU" term="%22Symmans+WF%22">Symmans WF</searchLink>; The University of Texas, MD Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Rugo+HS%22">Rugo HS</searchLink>; University of California, San Francisco, San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Melisko+ME%22">Melisko ME</searchLink>; University of California, San Francisco, San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Wallace+AM%22">Wallace AM</searchLink>; University of California, San Diego, La Jolla, CA.<br /><searchLink fieldCode="AU" term="%22Schwab+R%22">Schwab R</searchLink>; University of California, San Diego, La Jolla, CA.<br /><searchLink fieldCode="AU" term="%22Helsten+T%22">Helsten T</searchLink>; University of California, San Diego, La Jolla, CA.<br /><searchLink fieldCode="AU" term="%22Forero-Torres+A%22">Forero-Torres A</searchLink>; University of Alabama at Birmingham, Birmingham, AL.<br /><searchLink fieldCode="AU" term="%22Stringer-Reasor+E%22">Stringer-Reasor E</searchLink>; University of Alabama at Birmingham, Birmingham, AL.<br /><searchLink fieldCode="AU" term="%22Ellis+ED%22">Ellis ED</searchLink>; Swedish Cancer Institute, Seattle, WA.<br /><searchLink fieldCode="AU" term="%22Kaplan+HG%22">Kaplan HG</searchLink>; Swedish Cancer Institute, Seattle, WA.<br /><searchLink fieldCode="AU" term="%22Nanda+R%22">Nanda R</searchLink>; The University of Chicago Medical Center, Chicago, IL.<br /><searchLink fieldCode="AU" term="%22Jaskowiak+N%22">Jaskowiak N</searchLink>; The University of Chicago Medical Center, Chicago, IL.<br /><searchLink fieldCode="AU" term="%22Murthy+R%22">Murthy R</searchLink>; The University of Texas, MD Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Godellas+C%22">Godellas C</searchLink>; Loyola University, Chicago, IL.<br /><searchLink fieldCode="AU" term="%22Boughey+JC%22">Boughey JC</searchLink>; Mayo Clinic, Rochester, MN.<br /><searchLink fieldCode="AU" term="%22Elias+AD%22">Elias AD</searchLink>; University of Colorado Denver, Denver, CO.<br /><searchLink fieldCode="AU" term="%22Haley+BB%22">Haley BB</searchLink>; University of Texas Southwestern, Dallas, TX.<br /><searchLink fieldCode="AU" term="%22Kemmer+K%22">Kemmer K</searchLink>; Oregon Health & Science University, Portland, OR.<br /><searchLink fieldCode="AU" term="%22Isaacs+C%22">Isaacs C</searchLink>; Georgetown University, Washington, DC.<br /><searchLink fieldCode="AU" term="%22Clark+AS%22">Clark AS</searchLink>; University of Pennsylvania, Philadelphia, PA.<br /><searchLink fieldCode="AU" term="%22Lang+JE%22">Lang JE</searchLink>; University of Southern California, Los Angeles, CA.<br /><searchLink fieldCode="AU" term="%22Lu+J%22">Lu J</searchLink>; University of Southern California, Los Angeles, CA.<br /><searchLink fieldCode="AU" term="%22Korde+L%22">Korde L</searchLink>; Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD.<br /><searchLink fieldCode="AU" term="%22Edmiston+KK%22">Edmiston KK</searchLink>; Inova Health System, Falls Church, VA.<br /><searchLink fieldCode="AU" term="%22Northfelt+DW%22">Northfelt DW</searchLink>; Mayo Clinic, Scottsdale, AZ.<br /><searchLink fieldCode="AU" term="%22Viscusi+RK%22">Viscusi RK</searchLink>; University of Arizona, Tucson, AZ.<br /><searchLink fieldCode="AU" term="%22Yee+D%22">Yee D</searchLink>; Masonic Cancer Center, University of Minnesota, Minneapolis, MN.<br /><searchLink fieldCode="AU" term="%22Perlmutter+J%22">Perlmutter J</searchLink>; Gemini Group, Bad Axe, MI.<br /><searchLink fieldCode="AU" term="%22Hylton+NM%22">Hylton NM</searchLink>; University of California, San Francisco, San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Van't+Veer+LJ%22">Van't Veer LJ</searchLink>; University of California, San Francisco, San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22DeMichele+A%22">DeMichele A</searchLink>; University of Pennsylvania, Philadelphia, PA.<br /><searchLink fieldCode="AU" term="%22Wilson+A%22">Wilson A</searchLink>; Quantum Leap Healthcare Collaborative, San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Peterson+G%22">Peterson G</searchLink>; University of California, San Francisco, San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Buxton+MB%22">Buxton MB</searchLink>; Berry Consultants, Austin, TX.<br /><searchLink fieldCode="AU" term="%22Paoloni+M%22">Paoloni M</searchLink>; Berry Consultants, Austin, TX.<br /><searchLink fieldCode="AU" term="%22Clennell+J%22">Clennell J</searchLink>; Berry Consultants, Austin, TX.<br /><searchLink fieldCode="AU" term="%22Berry+S%22">Berry S</searchLink>; Berry Consultants, Austin, TX.<br /><searchLink fieldCode="AU" term="%22Matthews+JB%22">Matthews JB</searchLink>; University of California, San Francisco, San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Steeg+K%22">Steeg K</searchLink>; University of California, San Francisco, San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Singhrao+R%22">Singhrao R</searchLink>; University of California, San Francisco, San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Hirst+GL%22">Hirst GL</searchLink>; University of California, San Francisco, San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Sanil+A%22">Sanil A</searchLink>; Berry Consultants, Austin, TX.<br /><searchLink fieldCode="AU" term="%22Yau+C%22">Yau C</searchLink>; University of California, San Francisco, San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Asare+SM%22">Asare SM</searchLink>; Quantum Leap Healthcare Collaborative, San Francisco, CA.<br /><searchLink fieldCode="AU" term="%22Berry+DA%22">Berry DA</searchLink>; Berry Consultants, Austin, TX.<br /><searchLink fieldCode="AU" term="%22Esserman+LJ%22">Esserman LJ</searchLink>; University of California, San Francisco, San Francisco, CA.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22I-SPY+2+Consortium%22">I-SPY 2 Consortium</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228309333%22">Journal of clinical oncology : official journal of the American Society of Clinical Oncology</searchLink> [J Clin Oncol] 2020 Apr 01; Vol. 38 (10), pp. 1059-1069. <i>Date of Electronic Publication: </i>2019 Feb 07.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Adaptive Clinical Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Clinical+Oncology%22">American Society of Clinical Oncology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8309333 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1527-7755 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220732183X%22">0732183X </searchLink><i>NLM ISO Abbreviation: </i>J Clin Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32031889
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1200/JCO.19.01027
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1059
    Titles:
      – TitleFull: MK-2206 and Standard Neoadjuvant Chemotherapy Improves Response in Patients With Human Epidermal Growth Factor Receptor 2-Positive and/or Hormone Receptor-Negative Breast Cancers in the I-SPY 2 Trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Chien AJ
      – PersonEntity:
          Name:
            NameFull: Tripathy D
      – PersonEntity:
          Name:
            NameFull: Albain KS
      – PersonEntity:
          Name:
            NameFull: Symmans WF
      – PersonEntity:
          Name:
            NameFull: Rugo HS
      – PersonEntity:
          Name:
            NameFull: Melisko ME
      – PersonEntity:
          Name:
            NameFull: Wallace AM
      – PersonEntity:
          Name:
            NameFull: Schwab R
      – PersonEntity:
          Name:
            NameFull: Helsten T
      – PersonEntity:
          Name:
            NameFull: Forero-Torres A
      – PersonEntity:
          Name:
            NameFull: Stringer-Reasor E
      – PersonEntity:
          Name:
            NameFull: Ellis ED
      – PersonEntity:
          Name:
            NameFull: Kaplan HG
      – PersonEntity:
          Name:
            NameFull: Nanda R
      – PersonEntity:
          Name:
            NameFull: Jaskowiak N
      – PersonEntity:
          Name:
            NameFull: Murthy R
      – PersonEntity:
          Name:
            NameFull: Godellas C
      – PersonEntity:
          Name:
            NameFull: Boughey JC
      – PersonEntity:
          Name:
            NameFull: Elias AD
      – PersonEntity:
          Name:
            NameFull: Haley BB
      – PersonEntity:
          Name:
            NameFull: Kemmer K
      – PersonEntity:
          Name:
            NameFull: Isaacs C
      – PersonEntity:
          Name:
            NameFull: Clark AS
      – PersonEntity:
          Name:
            NameFull: Lang JE
      – PersonEntity:
          Name:
            NameFull: Lu J
      – PersonEntity:
          Name:
            NameFull: Korde L
      – PersonEntity:
          Name:
            NameFull: Edmiston KK
      – PersonEntity:
          Name:
            NameFull: Northfelt DW
      – PersonEntity:
          Name:
            NameFull: Viscusi RK
      – PersonEntity:
          Name:
            NameFull: Yee D
      – PersonEntity:
          Name:
            NameFull: Perlmutter J
      – PersonEntity:
          Name:
            NameFull: Hylton NM
      – PersonEntity:
          Name:
            NameFull: Van't Veer LJ
      – PersonEntity:
          Name:
            NameFull: DeMichele A
      – PersonEntity:
          Name:
            NameFull: Wilson A
      – PersonEntity:
          Name:
            NameFull: Peterson G
      – PersonEntity:
          Name:
            NameFull: Buxton MB
      – PersonEntity:
          Name:
            NameFull: Paoloni M
      – PersonEntity:
          Name:
            NameFull: Clennell J
      – PersonEntity:
          Name:
            NameFull: Berry S
      – PersonEntity:
          Name:
            NameFull: Matthews JB
      – PersonEntity:
          Name:
            NameFull: Steeg K
      – PersonEntity:
          Name:
            NameFull: Singhrao R
      – PersonEntity:
          Name:
            NameFull: Hirst GL
      – PersonEntity:
          Name:
            NameFull: Sanil A
      – PersonEntity:
          Name:
            NameFull: Yau C
      – PersonEntity:
          Name:
            NameFull: Asare SM
      – PersonEntity:
          Name:
            NameFull: Berry DA
      – PersonEntity:
          Name:
            NameFull: Esserman LJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2020 Apr 01
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 1527-7755
          Numbering:
            – Type: volume
              Value: 38
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
              Type: main
ResultId 1